The immunomodulatory activity of a drug would improve the efficacy of immunotherapy in breast cancer

(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) * The team of Eva Gonz á lez-Suarez, from the CNIO and IDIBELL, and the team of Christos Sotiriou, from the Jules Bordet Institute, demonstrate that a drug already used to treat osteoporosis promotes the infiltration of immune cells in breast tumours* These findings propose a new target to increase the antitumor immune response and make breast cancer more sensitive to immunotherapy
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news